From Barriers to Breakthroughs: Improving GLP-1 RA Adherence and Access Through Collaboration
GLP-1 receptor agonists (GLP-1 RAs) are powerful tools for managing type 2 diabetes (T2D) but concerns about adverse events (AEs) frequently stop patients before they start, and patients who are not prepared to manage common side effects may discontinue GLP-1 …